XGENE CORP has a total of 12 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are FUNDACIÓN PÚBLICA ANDALUZA PROGRESO Y SALUD, ROSLIN INST EDINBURGH and GENOVIE AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Analysing materials | |
#4 | Measuring microorganism processes | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Therapeutic chemical compounds | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Hoeffler Warren | 6 |
#2 | Hoeffler Warren K | 6 |
#3 | Finlay Deborah | 5 |
Publication | Filing date | Title |
---|---|---|
US2008279830A1 | Spongy epithelial cell scaffold for vascularizing wounds | |
AU3076802A | In vitro synthesis of a layered cell sorted tissue | |
US6913880B1 | Method for determining transcription factor activity and its technical uses | |
CA2346364A1 | Method for determining transcription factor activity and its technical uses |